*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| Z171 - Estrogen receptor negative status [ER-] - as a primary or secondary diagnosis code | ||
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | ||
| Readmission Rate (%) | ||
| Unplanned Readmission Rate (%) | 16.72 | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 580: OTHER SKIN, SUBCUTANEOUS TISSUE AND BREAST PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 581: OTHER SKIN, SUBCUTANEOUS TISSUE AND BREAST PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 809: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 598: MALIGNANT BREAST DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 32,775 | ||||
| Total Hospitalizations with ICD Z171 - Estrogen receptor negative status [ER-] | 440 | ||||
| DRG Share of Total Hospitalizations | 0.1 | ||||
| % of Total ICD Z171 - Estrogen receptor negative status [ER-] in DRG | 5.35 | ||||
| Avg LOS at DRG | 4.93 | ||||
| Avg LOS with ICD Z171 - Estrogen receptor negative status [ER-] | 3.02 | ||||
| Readmission Rate at DRG | 16.64 | ||||
| Readmission Rate with ICD Z171 - Estrogen receptor negative status [ER-] | 11.42 | ||||
| Unplanned Readmission Rate at DRG | 9.37 | ||||
| Unplanned Readmission Rate with ICD Z171 - Estrogen receptor negative status [ER-] | 8.16 | ||||
| Total Medicare payments at DRG | $321,966,863 | ||||
| Total Medicare payments with ICD Z171 - Estrogen receptor negative status [ER-] | $3,628,202 | ||||
| Total Medicare payment per Day at DRG | $1,993 | ||||
| Total Medicare payment per Day with ICD Z171 - Estrogen receptor negative status [ER-] | $2,726 | ||||
| Total Medicare payment per Hospitalization at DRG | $9,824 | ||||
| Total Medicare payment per Hospitalization with ICD Z171 - Estrogen receptor negative status [ER-] | $8,246 | ||||
| Total Medicare Charges at DRG | $1,646,314,545 | ||||
| Total Medicare Charges with ICD Z171 - Estrogen receptor negative status [ER-] | $25,599,817 | ||||
| Avg Charges at DRG | $50,231 | ||||
| Avg Charges with ICD Z171 - Estrogen receptor negative status [ER-] | $58,181 | ||||
| Mortality Rate at DRG | 0.09 | ||||
| Mortality Rate with ICD Z171 - Estrogen receptor negative status [ER-] | NA | ||||
| SNF Discharge Rate at DRG | 17.01 | ||||
| SNF Discharge Rate with ICD Z171 - Estrogen receptor negative status [ER-] | 12.95 | ||||
| Home Discharge Rate at DRG | 43.69 | ||||
| Home Discharge Rate with ICD Z171 - Estrogen receptor negative status [ER-] | 46.82 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 054: NERVOUS SYSTEM NEOPLASMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 597: MALIGNANT BREAST DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 582: MASTECTOMY FOR MALIGNANCY WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 43,598 | ||||
| Total Hospitalizations with ICD Z171 - Estrogen receptor negative status [ER-] | 224 | ||||
| DRG Share of Total Hospitalizations | 0.13 | ||||
| % of Total ICD Z171 - Estrogen receptor negative status [ER-] in DRG | 2.72 | ||||
| Avg LOS at DRG | 5.58 | ||||
| Avg LOS with ICD Z171 - Estrogen receptor negative status [ER-] | 5.62 | ||||
| Readmission Rate at DRG | 27.89 | ||||
| Readmission Rate with ICD Z171 - Estrogen receptor negative status [ER-] | 22.28 | ||||
| Unplanned Readmission Rate at DRG | 14.61 | ||||
| Unplanned Readmission Rate with ICD Z171 - Estrogen receptor negative status [ER-] | 15.84 | ||||
| Total Medicare payments at DRG | $420,580,748 | ||||
| Total Medicare payments with ICD Z171 - Estrogen receptor negative status [ER-] | $1,993,529 | ||||
| Total Medicare payment per Day at DRG | $1,728 | ||||
| Total Medicare payment per Day with ICD Z171 - Estrogen receptor negative status [ER-] | $1,583 | ||||
| Total Medicare payment per Hospitalization at DRG | $9,647 | ||||
| Total Medicare payment per Hospitalization with ICD Z171 - Estrogen receptor negative status [ER-] | $8,900 | ||||
| Total Medicare Charges at DRG | $2,165,508,049 | ||||
| Total Medicare Charges with ICD Z171 - Estrogen receptor negative status [ER-] | $11,376,363 | ||||
| Avg Charges at DRG | $49,670 | ||||
| Avg Charges with ICD Z171 - Estrogen receptor negative status [ER-] | $50,787 | ||||
| Mortality Rate at DRG | 4.23 | ||||
| Mortality Rate with ICD Z171 - Estrogen receptor negative status [ER-] | 4.91 | ||||
| SNF Discharge Rate at DRG | 18.01 | ||||
| SNF Discharge Rate with ICD Z171 - Estrogen receptor negative status [ER-] | 13.84 | ||||
| Home Discharge Rate at DRG | 29.57 | ||||
| Home Discharge Rate with ICD Z171 - Estrogen receptor negative status [ER-] | 37.05 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 810: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 180: RESPIRATORY NEOPLASMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 583: MASTECTOMY FOR MALIGNANCY WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 948: SIGNS AND SYMPTOMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 310,318 | ||||
| Total Hospitalizations with ICD Z171 - Estrogen receptor negative status [ER-] | 130 | ||||
| DRG Share of Total Hospitalizations | 0.94 | ||||
| % of Total ICD Z171 - Estrogen receptor negative status [ER-] in DRG | 1.58 | ||||
| Avg LOS at DRG | 3.19 | ||||
| Avg LOS with ICD Z171 - Estrogen receptor negative status [ER-] | 3.21 | ||||
| Readmission Rate at DRG | 20.19 | ||||
| Readmission Rate with ICD Z171 - Estrogen receptor negative status [ER-] | 31.2 | ||||
| Unplanned Readmission Rate at DRG | 13.62 | ||||
| Unplanned Readmission Rate with ICD Z171 - Estrogen receptor negative status [ER-] | 22.4 | ||||
| Total Medicare payments at DRG | $1,415,392,709 | ||||
| Total Medicare payments with ICD Z171 - Estrogen receptor negative status [ER-] | $648,044 | ||||
| Total Medicare payment per Day at DRG | $1,431 | ||||
| Total Medicare payment per Day with ICD Z171 - Estrogen receptor negative status [ER-] | $1,554 | ||||
| Total Medicare payment per Hospitalization at DRG | $4,561 | ||||
| Total Medicare payment per Hospitalization with ICD Z171 - Estrogen receptor negative status [ER-] | $4,985 | ||||
| Total Medicare Charges at DRG | $7,113,640,596 | ||||
| Total Medicare Charges with ICD Z171 - Estrogen receptor negative status [ER-] | $3,284,425 | ||||
| Avg Charges at DRG | $22,924 | ||||
| Avg Charges with ICD Z171 - Estrogen receptor negative status [ER-] | $25,265 | ||||
| Mortality Rate at DRG | 0.63 | ||||
| Mortality Rate with ICD Z171 - Estrogen receptor negative status [ER-] | NA | ||||
| SNF Discharge Rate at DRG | 19.76 | ||||
| SNF Discharge Rate with ICD Z171 - Estrogen receptor negative status [ER-] | 12.31 | ||||
| Home Discharge Rate at DRG | 50.47 | ||||
| Home Discharge Rate with ICD Z171 - Estrogen receptor negative status [ER-] | 56.92 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 948: SIGNS AND SYMPTOMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | DRG 181: RESPIRATORY NEOPLASMS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 160,950 | ||||
| Total Hospitalizations with ICD Z171 - Estrogen receptor negative status [ER-] | 100 | ||||
| DRG Share of Total Hospitalizations | 0.49 | ||||
| % of Total ICD Z171 - Estrogen receptor negative status [ER-] in DRG | 1.22 | ||||
| Avg LOS at DRG | 4.98 | ||||
| Avg LOS with ICD Z171 - Estrogen receptor negative status [ER-] | 4.0 | ||||
| Readmission Rate at DRG | 20.85 | ||||
| Readmission Rate with ICD Z171 - Estrogen receptor negative status [ER-] | 37.36 | ||||
| Unplanned Readmission Rate at DRG | 13.4 | ||||
| Unplanned Readmission Rate with ICD Z171 - Estrogen receptor negative status [ER-] | 23.08 | ||||
| Total Medicare payments at DRG | $1,184,949,733 | ||||
| Total Medicare payments with ICD Z171 - Estrogen receptor negative status [ER-] | $505,874 | ||||
| Total Medicare payment per Day at DRG | $1,477 | ||||
| Total Medicare payment per Day with ICD Z171 - Estrogen receptor negative status [ER-] | $1,265 | ||||
| Total Medicare payment per Hospitalization at DRG | $7,362 | ||||
| Total Medicare payment per Hospitalization with ICD Z171 - Estrogen receptor negative status [ER-] | $5,059 | ||||
| Total Medicare Charges at DRG | $4,222,078,897 | ||||
| Total Medicare Charges with ICD Z171 - Estrogen receptor negative status [ER-] | $2,764,557 | ||||
| Avg Charges at DRG | $26,232 | ||||
| Avg Charges with ICD Z171 - Estrogen receptor negative status [ER-] | $27,646 | ||||
| Mortality Rate at DRG | 0.67 | ||||
| Mortality Rate with ICD Z171 - Estrogen receptor negative status [ER-] | NA | ||||
| SNF Discharge Rate at DRG | 22.29 | ||||
| SNF Discharge Rate with ICD Z171 - Estrogen receptor negative status [ER-] | 13.0 | ||||
| Home Discharge Rate at DRG | 35.46 | ||||
| Home Discharge Rate with ICD Z171 - Estrogen receptor negative status [ER-] | 46.0 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 153 |
| MEMORIAL SLOAN KETTERING CANCER CENTER | 1275 YORK AVE | NEW YORK | NY | 10065 | 121 |
| BARNES JEWISH HOSPITAL | 1 BARNES-JEWISH HOSPITAL PLZ | SAINT LOUIS | MO | 63110 | 64 |